Preclinical monitoring of radiation-induced brain injury via GluCEST MRI and resting-state fMRI at 7 T: an exploratory study on MRI-guided OAR avoidance
Strahlentherapie und Onkologie · 2025-04 · 201 (4) · 411-419
DOI: 10.1007/s00066-024-02292-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Strahlentherapie und Onkologie, online erschienen am 11.09.2024. Verfasst von Guodong Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Binzhou Medical University Hospital, School of Medical Imaging, Binzhou Medical University, Shandong, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Glutamic Acid, Radiation Injuries, Radiation Injuries, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: the National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: To assess the value of glutamate chemical exchange saturation transfer (GluCEST) after whole-brain radiotherapy (WBRT) as an imaging marker of radiation-induced brain injury (RBI) and to preliminarily show the feasibility of multiparametric MRI-guided organ at risk (OAR) avoidance. METHODS: Rats were divided into two groups: the control (CTRL) group (n = 9) and the RBI group (n = 9). The rats in the RBI group were irradiated with an X‑ray radiator and then subjected to a water maze experiment 4 weeks later. In combination with high-performance liquid chromatography (HPLC), we evaluated the value of GluCEST applied to glutamate changes for RBI and investigated the effect of such changes on glutamatergic neuronal function. RESULTS: The average GluCEST values were markedly lower in the hippocampus and cerebral cortex. Positive correlations were observed between GluCEST values and regional homogeneity (ReHo) values in both the hippocampus and the cerebral cortex. HPLC showed a positive correlation with GluCEST values in the hippocampus. GluCEST values were positively correlated with spatial memory. CONCLUSION: GluCEST MRI provides a visual assessment of glutamate changes in RBI rats for monitoring OAR cognitive toxicity reactions and may be used as a biomarker of OAR avoidance as well as metabolism to facilitate monitoring and intervention in radiation damage that occurs after radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Binzhou Medical University Hospital, School of Medical Imaging, Binzhou Medical University, Shandong, China.
- Department of Nuclear Medicine, Binzhou Medical University Hospital, School of Medical Imaging, Binzhou Medical University, Shandong, China. liuericyan@hotmail.com.
- Department of Nuclear Medicine, Binzhou Medical University Hospital, School of Medical Imaging, Binzhou Medical University, Shandong, China. wangxu1978@163.com.
ORCID-Profile: Xu Wang
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Li, G., Li, H., Weng, N., Liu, C., Li, X., Li, Q., Bin, L., Zhu, K., Huang, D., Liu, J., Liu, Y., & Wang, X. (2025). Preclinical monitoring of radiation-induced brain injury via GluCEST MRI and resting-state fMRI at 7 T: an exploratory study on MRI-guided OAR avoidance. Strahlentherapie und Onkologie, 201(4), 411-419. https://doi.org/10.1007/s00066-024-02292-w
Vancouver
Li G, Li H, Weng N, Liu C, Li X, Li Q, et al. Preclinical monitoring of radiation-induced brain injury via GluCEST MRI and resting-state fMRI at 7 T: an exploratory study on MRI-guided OAR avoidance. Strahlentherapie und Onkologie. 2025;201(4):411-419. doi:10.1007/s00066-024-02292-w
BibTeX
@article{Li2025,
author = {Li, Guodong and Li, Hao and Weng, Na and Liu, Caiyun and Li, Xianglin and Li, Qinglong and Bin, Li and Zhu, Kai and Huang, Danqi and Liu, Jia and Liu, Yan and Wang, Xu},
title = {Preclinical monitoring of radiation-induced brain injury via GluCEST MRI and resting-state fMRI at 7 T: an exploratory study on MRI-guided OAR avoidance},
journal = {Strahlentherapie und Onkologie},
year = {2025},
volume = {201},
number = {4},
pages = {411--419},
doi = {10.1007/s00066-024-02292-w}
}
EUVIMED